69
Views
6
CrossRef citations to date
0
Altmetric
Original Research

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

, , , , , , , & show all
Pages 9-17 | Published online: 01 Mar 2013

References

  • SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
  • LefebvreJLCurrent clinical outcomes demand new treatment options for SCCHNAnn Oncol200516Suppl 6vi7vi1215987995
  • ArgirisABrocksteinBEHarafDJCompeting causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapyClin Cancer Res20041061956196215041712
  • KhuriFRKimESLeeJJThe impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialCancer Epidemiol Biomarkers Prev200110882382911489748
  • SanabriaACarvalhoALVartanianJGMagrinJIkedaMKKowalskiLPFactors that influence treatment decision in older patients with resectable head and neck cancerLaryngoscope2007117583584017473679
  • SanabriaACarvalhoALVartanianJGMagrinJIkedaMKKowalskiLPComorbidity is a prognostic factor in elderly patients with head and neck cancerAnn Surg Oncol20071441449145717235712
  • HopkinsJCesconDWTseDGenetic polymorphisms and head and neck cancer outcomes: a reviewCancer Epidemiol Biomarkers Prev200817349049918349267
  • PearsonWRVorachekWRXuSJIdentification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13Am J Hum Genet19935312202338317488
  • XuSWangYRoeBPearsonWRCharacterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletionJ Biol Chem19982736351735279452477
  • RoweJDNievesEListowskyISubunit diversity and tissue distribution of human glutathione S-transferases: interpretations based on electrospray ionization-MS and peptide sequence-specific antiseraBiochem J1997325Pt 24814869230131
  • GeislerSAOlshanAFGSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE reviewAm J Epidemiol200115429510511447041
  • SongDKXingDLZhangLRLiZXLiuJQiaoBPAssociation of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central ChinaCancer Detect Prev2009325–641642319303722
  • GolkaKHermesMSelinskiSSusceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposurePharmacogenet Genomics2009191190390619801959
  • OlivieriEHda SilvaSDMendonçaFFCYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patientsOral Oncol2009459e73e7919442564
  • SyamalaVSSreejaLSyamalaVInfluence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survivalFam Cancer20087321322018080216
  • PandeySNJainMNigamPChoudhuriGMittalBGenetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North IndiaBiomarkers200611325026116760134
  • SharmaAMishraADasBCSardanaSSharmaJKGenetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancerNeoplasma200653430931516830058
  • KingRSTeitelCHKadlubarFFIn vitro bioactivation of N-hydroxy-2-amino-alpha-carbolineCarcinogenesis20002171347135410874013
  • ColesBFKadlubarFFDetoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?Biofactors2003171–411513012897434
  • HildebrandtMALippmanSMEtzelCJGenetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemopreventionClin Cancer Res201218133705371322577058
  • WangJLippmanSMLeeJJGenetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinomaCarcinogenesis201031101755176120627871
  • WuXSpitzMRLeeJJNovel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variantsCancer Prev Res (Phila)20092761762419584075
  • ZhangXYangHLeeJJMicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerCarcinogenesis201031122118212320819778
  • KhuriFRLippmanSMSpitzMRLotanRHongWKMolecular epidemiology and retinoid chemoprevention of head and neck cancerJ Natl Cancer Inst19978931992119017000
  • DikshitRPBoffettaPBouchardyCRisk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinomaCancer2005103112326233315852357
  • RussoACrosignaniPBerrinoFTobacco smoking, alcohol drinking and dietary factors as determinants of new primaries among male laryngeal cancer patients: a case-cohort studyTumori19968265195259061057
  • VineisPPirastuRAromatic amines and cancerCancer Causes Control1997833463559498898
  • HashibeMBrennanPStrangeRCMeta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancerCancer Epidemiol Biomarkers Prev200312121509151714693745
  • ChengLSturgisEMEicherSACharDSpitzMRWeiQGlutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neckInt J Cancer199984322022410371337
  • MinardCGSpitzMRWuXHongWKEtzelCJEvaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancerCancer2006106122636264416703596
  • SinghMShahPPSinghAPAssociation of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancerMutat Res20086381–218419418035380
  • MatthiasCHarréusUStrangeRInfluential factors on tumor recurrence in head and neck cancer patientsEur Arch Otorhinolaryngol20062631374216003553
  • ZafereoMESturgisEMAleemSChaungKWeiQLiGGlutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neckCancer Prev Res (Phila Pa)200925432439
  • GeislerSAOlshanAFCaiJWeisslerMSmithJBellDGlutathione S-transferase polymorphisms and survival from head and neck cancerHead Neck200527323224215668931
  • WorrallSFCorriganMHighASusceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6Pharmacogenetics1998854334399825835
  • NørskovMSFrikke-SchmidtRBojesenSENordestgaardBGLoftSTybjærg-HansenACopy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general populationPharmacogenomics J201111429229920514077
  • McLellanRAOscarsonMAlexandrieAKCharacterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activityMol Pharmacol19975269589659415705
  • BartleyPAKeoughRALutwycheJKGondaTJRegulation of the gene encoding glutathione S-transferase M1 (GSTM1) by the Myb oncoproteinOncogene200322487570757514576818
  • YuKDDiGHFanLA functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancerFASEB J20092372274228719228880